EC Seeks Industry Feedback to Shape Serialization Policy

| 24 November 2011

The European Commission (EC) is seeking industry comments before implementing the serialization aspect of the falsified medicines directive.  Adoption of the falsified medicines directive will make the use of unique identifiers to verify the authenticity of individual drug packages mandatory.  However, the details are still to be decided and the EC is requesting input from industry prior to making its decision.  It is hoped that the EC's harmonization of the unique identifiers will lead to the smoother implementation of the serialization process. (In-Pharma Technologist)


© 2022 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy